Teva sells Quebec plant to Halo; Visionspect launches industry's first contract visual inspection device;

> Royal DSM's DSM Pharmaceutical Products was honored as the best contract manufacturing organization by Biopharma Asia at its Second Annual Biopharma Asia Industry Awards in Singapore. Release

> After an 8-month effort, Teva Pharmaceutical Industries ($TEVA) has sold its Quebec plant to Halo Pharmaceuticals ($HALO), which the latter will use to expand its efforts in contract manufacturing. Article

> San Diego CRO Althea Technologies grabbed the worldwide rights to Allena Pharmaceuticals' Hyperoxaluria portfolio. Release

> GE Healthcare ups its molecular diagnostics game. Article

> Visionspect, a division of DJA Pharma, announced that it completed the industry's first contract visual inspection system, which is expected to help clients save operating costs. Release

BD&L Summit

Deal-Making Insights for the Life Sciences Industry

Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.